Miller DM - Search Results

1

Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.

Rao SM, Galioto R, Sokolowski M, McGinley M, Freiburger J, Weber M, Dey T, Mourany L, Schindler D, Reece C, Miller DM, Bethoux F, Bermel RA, Williams JR, Levitt N, Phillips GA, Rhodes JK, Alberts J, Rudick RA. Rao SM, et al. Among authors: miller dm. Eur J Neurol. 2020 May;27(5):878-886. doi: 10.1111/ene.14162. Epub 2020 Mar 2. Eur J Neurol. 2020. PMID: 32009276

2

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.

Miller DM, Weinstock-Guttman B, Béthoux F, Lee JC, Beck G, Block V, Durelli L, LaMantia L, Barnes D, Sellebjerg F, Rudick RA. Miller DM, et al. Mult Scler. 2000 Aug;6(4):267-73. doi: 10.1177/135245850000600408. Mult Scler. 2000. PMID: 10962547

3

Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.

Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS. Miller DM, et al. Arch Neurol. 2000 Sep;57(9):1319-24. doi: 10.1001/archneur.57.9.1319. Arch Neurol. 2000. PMID: 10987899

4

Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life.

Bethoux F, Miller DM, Kinkel RP. Bethoux F, et al. Among authors: miller dm. Mult Scler. 2001 Apr;7(2):137-42. doi: 10.1177/135245850100700210. Mult Scler. 2001. PMID: 11424634

5

Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis.

Miller DM, Rudick RA, Baier M, Cutter G, Doughtery DS, Weinstock-Guttman B, Mass MK, Fisher E, Simonian N. Miller DM, et al. Mult Scler. 2003 Feb;9(1):1-5. doi: 10.1191/1352458503ms888oa. Mult Scler. 2003. PMID: 12617260 Clinical Trial.

6

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Marrie RA, Miller DM, Chelune GJ, Cohen JA. Marrie RA, et al. Among authors: miller dm. Mult Scler. 2003 Dec;9(6):621-6. doi: 10.1191/1352458503ms971oa. Mult Scler. 2003. PMID: 14664477

7

Association of fatigue and brain atrophy in multiple sclerosis.

Marrie RA, Fisher E, Miller DM, Lee JC, Rudick RA. Marrie RA, et al. Among authors: miller dm. J Neurol Sci. 2005 Feb 15;228(2):161-6. doi: 10.1016/j.jns.2004.11.046. Epub 2004 Dec 21. J Neurol Sci. 2005. PMID: 15694198

8

Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients.

Rudick RA, Cutter GR, Baier M, Weinstock-Guttman B, Mass MK, Fisher E, Miller DM, Sandrock AW. Rudick RA, et al. Among authors: miller dm. Mult Scler. 2005 Dec;11(6):626-34. doi: 10.1191/1352458505ms1203oa. Mult Scler. 2005. PMID: 16323317 Clinical Trial.

9

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA; AFFIRM and SENTINEL Investigators. Rudick RA, et al. Ann Neurol. 2007 Oct;62(4):335-46. doi: 10.1002/ana.21163. Ann Neurol. 2007. PMID: 17696126 Clinical Trial.

10

Health-related quality of life assessment in multiple sclerosis.

Miller DM, Kinkel RP. Miller DM, et al. Rev Neurol Dis. 2008 Spring;5(2):56-64. Rev Neurol Dis. 2008. PMID: 18660737 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters